Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eukaryotic Initiation Factor-2 | 17 | 2022 | 177 | 3.170 |
Why?
|
Urea | 6 | 2019 | 448 | 1.870 |
Why?
|
eIF-2 Kinase | 6 | 2018 | 145 | 1.820 |
Why?
|
Peptide Chain Initiation, Translational | 3 | 2013 | 100 | 0.870 |
Why?
|
Phosphorylation | 21 | 2022 | 8278 | 0.810 |
Why?
|
Antineoplastic Agents | 19 | 2019 | 13648 | 0.760 |
Why?
|
Protein Biosynthesis | 13 | 2023 | 2086 | 0.740 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 565 | 0.720 |
Why?
|
RNA, Transfer, Met | 3 | 2015 | 14 | 0.630 |
Why?
|
Heme | 2 | 2019 | 316 | 0.610 |
Why?
|
Clotrimazole | 2 | 2013 | 77 | 0.590 |
Why?
|
Biphenyl Compounds | 1 | 2022 | 1019 | 0.570 |
Why?
|
Guanosine Triphosphate | 2 | 2015 | 313 | 0.560 |
Why?
|
Eukaryotic Initiation Factor-4G | 5 | 2014 | 68 | 0.510 |
Why?
|
Chromans | 3 | 2013 | 116 | 0.500 |
Why?
|
Structure-Activity Relationship | 13 | 2019 | 3051 | 0.490 |
Why?
|
Hydrazones | 6 | 2014 | 105 | 0.480 |
Why?
|
Thiazolidinediones | 5 | 2013 | 459 | 0.450 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1087 | 0.450 |
Why?
|
Enzyme Activators | 1 | 2013 | 56 | 0.440 |
Why?
|
Thiazoles | 8 | 2014 | 1529 | 0.430 |
Why?
|
Benzopyrans | 1 | 2013 | 62 | 0.420 |
Why?
|
Eukaryotic Initiation Factor-4E | 4 | 2014 | 111 | 0.390 |
Why?
|
Fish Oils | 1 | 2015 | 483 | 0.370 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2010 | 314 | 0.350 |
Why?
|
Cyclic AMP | 3 | 2003 | 1467 | 0.350 |
Why?
|
Oocytes | 3 | 2003 | 1169 | 0.330 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2019 | 720 | 0.310 |
Why?
|
Cell Line, Tumor | 19 | 2019 | 17075 | 0.300 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1153 | 0.300 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2010 | 394 | 0.280 |
Why?
|
Cell Proliferation | 13 | 2019 | 10429 | 0.270 |
Why?
|
Molecular Structure | 4 | 2019 | 1885 | 0.270 |
Why?
|
RNA, Messenger | 7 | 2023 | 12768 | 0.260 |
Why?
|
Prophase | 2 | 1995 | 16 | 0.260 |
Why?
|
Bacteriocins | 2 | 2019 | 85 | 0.250 |
Why?
|
Antigens, Surface | 1 | 2010 | 1617 | 0.250 |
Why?
|
NF-kappa B | 2 | 2013 | 2485 | 0.240 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11888 | 0.220 |
Why?
|
Interleukins | 2 | 2018 | 791 | 0.210 |
Why?
|
Granulosa Cells | 1 | 2003 | 120 | 0.210 |
Why?
|
Meiosis | 1 | 2003 | 326 | 0.180 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1874 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2019 | 10729 | 0.180 |
Why?
|
Indoles | 4 | 2013 | 1839 | 0.180 |
Why?
|
Activating Transcription Factor 4 | 2 | 2018 | 86 | 0.180 |
Why?
|
Nitro Compounds | 2 | 2012 | 74 | 0.170 |
Why?
|
Mice | 26 | 2021 | 81819 | 0.170 |
Why?
|
Mice, Nude | 4 | 2015 | 3618 | 0.170 |
Why?
|
Animals | 34 | 2021 | 168764 | 0.160 |
Why?
|
Clodronic Acid | 1 | 2019 | 60 | 0.160 |
Why?
|
Leishmania | 2 | 2017 | 75 | 0.160 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 484 | 0.160 |
Why?
|
Diphtheria Toxin | 1 | 2019 | 253 | 0.150 |
Why?
|
Trypanosoma brucei brucei | 1 | 2018 | 43 | 0.150 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5849 | 0.140 |
Why?
|
Cattle | 3 | 2003 | 3801 | 0.140 |
Why?
|
Complement System Proteins | 2 | 2011 | 715 | 0.140 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1997 | 111 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2013 | 3608 | 0.140 |
Why?
|
Models, Molecular | 4 | 2019 | 5379 | 0.140 |
Why?
|
Listeriosis | 1 | 2018 | 146 | 0.140 |
Why?
|
Cyclin D1 | 3 | 2013 | 449 | 0.130 |
Why?
|
Eukaryotic Initiation Factor-4F | 2 | 2017 | 41 | 0.130 |
Why?
|
Cell Cycle | 3 | 2010 | 2920 | 0.130 |
Why?
|
Macrophages | 4 | 2020 | 5772 | 0.130 |
Why?
|
Cyclins | 2 | 2001 | 598 | 0.130 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2017 | 137 | 0.130 |
Why?
|
Trypanosoma cruzi | 1 | 2018 | 200 | 0.130 |
Why?
|
Listeria monocytogenes | 1 | 2018 | 244 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 2 | 2013 | 461 | 0.120 |
Why?
|
Simplexvirus | 1 | 2019 | 807 | 0.120 |
Why?
|
Intracellular Fluid | 1 | 1995 | 201 | 0.120 |
Why?
|
Mice, Inbred DBA | 3 | 2013 | 623 | 0.120 |
Why?
|
Enzyme Activation | 3 | 2018 | 3586 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2004 | 1396 | 0.120 |
Why?
|
Drug Design | 2 | 2017 | 1042 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 558 | 0.110 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
Breast Neoplasms | 3 | 2018 | 21056 | 0.110 |
Why?
|
Calcium | 7 | 2004 | 5767 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2015 | 256 | 0.110 |
Why?
|
Oncogene Proteins | 1 | 1997 | 710 | 0.110 |
Why?
|
Neoplasms | 3 | 2018 | 22340 | 0.100 |
Why?
|
RNA Interference | 3 | 2017 | 2832 | 0.100 |
Why?
|
Transfection | 4 | 2013 | 5743 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 1997 | 1066 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 303 | 0.100 |
Why?
|
Protozoan Proteins | 1 | 2018 | 843 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2015 | 820 | 0.090 |
Why?
|
Catalysis | 1 | 2013 | 770 | 0.090 |
Why?
|
Humans | 39 | 2023 | 765968 | 0.090 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 295 | 0.090 |
Why?
|
Sulfonamides | 2 | 2004 | 1984 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.090 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2011 | 45 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2573 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2011 | 272 | 0.090 |
Why?
|
3T3 Cells | 4 | 2001 | 1081 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 1761 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3430 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2395 | 0.080 |
Why?
|
Signal Transduction | 5 | 2017 | 23601 | 0.080 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 651 | 0.080 |
Why?
|
Erythrocytes | 1 | 2017 | 2395 | 0.070 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 515 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 691 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 938 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 1997 | 2796 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2011 | 1347 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2631 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2007 | 282 | 0.070 |
Why?
|
Hydrogen | 1 | 2007 | 168 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2017 | 3141 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2011 | 506 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2822 | 0.060 |
Why?
|
Bordetella pertussis | 2 | 1995 | 45 | 0.060 |
Why?
|
Apoptosis | 2 | 2018 | 9514 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3946 | 0.060 |
Why?
|
Thiones | 1 | 2004 | 50 | 0.060 |
Why?
|
Cell Line | 3 | 2015 | 15543 | 0.060 |
Why?
|
Intestine, Small | 1 | 2011 | 1214 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7066 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 888 | 0.060 |
Why?
|
Heme Oxygenase-1 | 2 | 2017 | 364 | 0.060 |
Why?
|
Culture Media | 2 | 1995 | 890 | 0.050 |
Why?
|
Carbon | 1 | 2007 | 677 | 0.050 |
Why?
|
Stereoisomerism | 2 | 2014 | 614 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18293 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4044 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2014 | 3672 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2021 | 1770 | 0.050 |
Why?
|
Anemia, Hemolytic | 1 | 2003 | 164 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9550 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2844 | 0.050 |
Why?
|
Adipocytes | 1 | 2007 | 1194 | 0.040 |
Why?
|
Protein Binding | 4 | 2015 | 9296 | 0.040 |
Why?
|
Transcription Factors | 2 | 2015 | 12131 | 0.040 |
Why?
|
G1 Phase | 2 | 2018 | 403 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1211 | 0.040 |
Why?
|
Chemokine CX3CL1 | 1 | 2020 | 60 | 0.040 |
Why?
|
Infertility, Male | 1 | 2003 | 395 | 0.040 |
Why?
|
MPTP Poisoning | 1 | 2019 | 36 | 0.040 |
Why?
|
Platelet Activation | 1 | 2003 | 645 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2004 | 1075 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9601 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2021 | 3584 | 0.040 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2018 | 90 | 0.040 |
Why?
|
Female | 12 | 2020 | 396112 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2017 | 4260 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1997 | 185 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 852 | 0.030 |
Why?
|
Myoblasts | 1 | 2018 | 234 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1997 | 206 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 8611 | 0.030 |
Why?
|
Chagas Disease | 1 | 2018 | 163 | 0.030 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1995 | 99 | 0.030 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 1995 | 72 | 0.030 |
Why?
|
Thapsigargin | 1 | 2015 | 102 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2018 | 14448 | 0.030 |
Why?
|
Thionucleotides | 1 | 1995 | 108 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1995 | 283 | 0.030 |
Why?
|
Oogenesis | 1 | 1995 | 125 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 1995 | 318 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2011 | 6203 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2017 | 385 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 22332 | 0.030 |
Why?
|
Cell Division | 2 | 2001 | 4475 | 0.030 |
Why?
|
RNA Caps | 1 | 2014 | 72 | 0.030 |
Why?
|
Tumor Cells, Cultured | 3 | 2011 | 6113 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2081 | 0.030 |
Why?
|
Isoquinolines | 1 | 1995 | 350 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5719 | 0.030 |
Why?
|
Interferon-beta | 1 | 2015 | 346 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1997 | 660 | 0.030 |
Why?
|
Solutions | 1 | 2014 | 403 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 2015 | 302 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1997 | 561 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 2014 | 210 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 423 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 425 | 0.030 |
Why?
|
Protein Transport | 1 | 2018 | 1939 | 0.030 |
Why?
|
Fetus | 1 | 2020 | 1870 | 0.030 |
Why?
|
Lung | 2 | 2021 | 10033 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3273 | 0.020 |
Why?
|
Binding Sites | 2 | 2014 | 6001 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1242 | 0.020 |
Why?
|
Transcription Factor CHOP | 1 | 2011 | 69 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 446 | 0.020 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2011 | 7 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1210 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1679 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5786 | 0.020 |
Why?
|
Specimen Handling | 1 | 1995 | 704 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2007 | 18973 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.020 |
Why?
|
Cytotoxins | 1 | 2011 | 154 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11641 | 0.020 |
Why?
|
Complement Membrane Attack Complex | 1 | 2010 | 102 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2867 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 1947 | 0.020 |
Why?
|
Models, Chemical | 1 | 2011 | 608 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3681 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2017 | 2143 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4562 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3421 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 322 | 0.020 |
Why?
|
Male | 8 | 2020 | 363698 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5020 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1995 | 1652 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2446 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2942 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3222 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 462 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2140 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1524 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2007 | 206 | 0.020 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2007 | 9 | 0.020 |
Why?
|
Time Factors | 4 | 2011 | 40065 | 0.020 |
Why?
|
Angiotensin II | 1 | 2010 | 844 | 0.020 |
Why?
|
Cell Extracts | 1 | 2007 | 134 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 636 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2900 | 0.020 |
Why?
|
Entropy | 1 | 2007 | 208 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2007 | 451 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2007 | 434 | 0.020 |
Why?
|
Neoplasms, Experimental | 2 | 2001 | 1229 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 858 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2007 | 737 | 0.020 |
Why?
|
Granulocytes | 1 | 2007 | 549 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1997 | 4520 | 0.010 |
Why?
|
PPAR gamma | 1 | 2007 | 483 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2011 | 1069 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7562 | 0.010 |
Why?
|
Feedback, Physiological | 1 | 2007 | 480 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2010 | 1458 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 943 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 499 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2120 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7584 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9443 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4331 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5696 | 0.010 |
Why?
|
Cyclin G | 1 | 2001 | 7 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6220 | 0.010 |
Why?
|
Cyclin G1 | 1 | 2001 | 15 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23707 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1333 | 0.010 |
Why?
|
Sperm Motility | 1 | 2003 | 265 | 0.010 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2004 | 416 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17594 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6493 | 0.010 |
Why?
|
Oncogenes | 1 | 2007 | 1235 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5881 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9525 | 0.010 |
Why?
|
Cyclin E | 1 | 2000 | 156 | 0.010 |
Why?
|
Ploidies | 1 | 2000 | 287 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3750 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1646 | 0.010 |
Why?
|
Spermatozoa | 1 | 2003 | 629 | 0.010 |
Why?
|
Introns | 1 | 2001 | 966 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1372 | 0.010 |
Why?
|
Protein Conformation | 1 | 2006 | 3946 | 0.010 |
Why?
|
Ubiquitins | 1 | 2000 | 365 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1132 | 0.010 |
Why?
|
Cricetinae | 1 | 2001 | 2411 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4247 | 0.010 |
Why?
|
Organ Specificity | 1 | 2001 | 1965 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2717 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2001 | 1742 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5337 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2391 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2505 | 0.010 |
Why?
|
ras Proteins | 1 | 2000 | 1053 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13400 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5125 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2007 | 3985 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4618 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 4015 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2011 | 59489 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 9525 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16721 | 0.000 |
Why?
|
Young Adult | 1 | 2011 | 59889 | 0.000 |
Why?
|
Adolescent | 1 | 2011 | 88835 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 30198 | 0.000 |
Why?
|
Aged | 1 | 2011 | 171117 | 0.000 |
Why?
|
Middle Aged | 1 | 2011 | 223009 | 0.000 |
Why?
|
Adult | 1 | 2011 | 223044 | 0.000 |
Why?
|